EGFR-IN-11
|
E647319-5mg
|
≥99% |
2463200-44-2 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-11
|
E647319-50mg
|
≥99% |
2463200-44-2 |
50mg
|
¥ 22000.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-11
|
E647319-25mg
|
≥99% |
2463200-44-2 |
25mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-11
|
E647319-10mg
|
≥99% |
2463200-44-2 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-11
|
E647319-100mg
|
≥99% |
2463200-44-2 |
100mg
|
¥ 34000.9
|
期货,请咨询 |
阿拉丁 |
Elacytarabine
|
E647298-5mg
|
≥98% |
188181-42-2 |
5mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
Elacytarabine
|
E647298-50mg
|
≥98% |
188181-42-2 |
50mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Elacytarabine
|
E647298-10mg
|
≥98% |
188181-42-2 |
10mg
|
¥ 1900.9
|
期货,请咨询 |
阿拉丁 |
Elacytarabine
|
E647298-100mg
|
≥98% |
188181-42-2 |
100mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
EEDi-5285
|
E647281-5mg
|
≥99% |
2488952-40-3 |
5mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
EEDi-5285
|
E647281-10mg
|
≥99% |
2488952-40-3 |
10mg
|
¥ 9800.9
|
期货,请咨询 |
阿拉丁 |
EW-7195
|
E647270-5mg
|
≥99% |
1352609-28-9 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
EW-7195
|
E647270-25mg
|
≥99% |
1352609-28-9 |
25mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
EW-7195
|
E647270-10mg
|
≥99% |
1352609-28-9 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-69
|
E647157-5mg
|
≥99% |
2433837-65-9 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-69
|
E647157-50mg
|
≥99% |
2433837-65-9 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-69
|
E647157-25mg
|
≥99% |
2433837-65-9 |
25mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
EGFR-IN-69
|
E647157-10mg
|
≥99% |
2433837-65-9 |
10mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
Etilevodopa hydrochloride
|
E647142-5mg
|
≥99% |
39740-30-2 |
5mg
|
¥ 500.9
|
期货,请咨询 |
阿拉丁 |
Etilevodopa hydrochloride
|
E647142-50mg
|
≥99% |
39740-30-2 |
50mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
Etilevodopa hydrochloride
|
E647142-25mg
|
≥99% |
39740-30-2 |
25mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Etilevodopa hydrochloride
|
E647142-10mg
|
≥99% |
39740-30-2 |
10mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
Etilevodopa hydrochloride
|
E647142-100mg
|
≥99% |
39740-30-2 |
100mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Erythromycin-d6
|
E647129-1mg
|
|
959119-25-6 |
1mg
|
¥ 4750.9
|
期货,请咨询 |
阿拉丁 |